Review
Aug 2026
Experimental Evidence Supporting the Neuroprotective Role of Epigallocatechin-3-Gallate in Parkinson's Disease.
The available experimental results indicate that EGCG could be a successful neuroprotective and disease-modifying therapy for PD, and more clinical studies and improved delivery systems are needed to confirm its therapeutic potential in humans.
Ahsas Goyal, Sparsh Kaushal, Partyaksha Ruhella et al.
· Current Neurovascular Resear... · 0 citations